BIOGEN IDEC $210.80

up +3.05


18/6/2013 04:18 PM  |  NASDAQ : BIIB  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 210.80
Trade Time: Jun 18 4:04 PM Eastern Daylight Time
Change: 3.05 (1.47 %)
Prev Close: 207.75
Open: 210.47
Bid: 209.95
Ask: 210.72
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get BIIB Trend Analysis - it has outperformed the S&P 500 by 27%

ETF Alternatives



People viewing BIIB also viewed: , , , ,

Competitors

Ticker Name Volume % Change
RXEI RXELITE 45.2K +4.00%
ALSE ALSERES PHARMACEUTICALS 600.0 +1.00%
ALLP ALLIANCE PHARMACEUTICAL 3.5K +0.82%
KVPBQ K-V PHARMACEUTICAL 1.4K +0.82%
HRDN DC BRANDS INTERNATIONAL INC. C 16.7M +0.67%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
6/14/2013 DENNER ALEXANDER J Director -2,900 $212.00 -31.44%
6/11/2013 Posner Brian S Director -2,020 $219.62 -19.90%
6/11/2013 PAPADOPOULOS STELIOS Director -2,020 $219.62 -13.51%
6/10/2013 SCHENK LYNN Director -1,000 $225.67 -25.51%
6/10/2013 SCHENK LYNN Director -1,000 $225.96 -20.33%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (BIIB), click here.
View All

BIIB Stock Analysis

  1. Perrigo in Expansion Mode - Analyst Blog

    (SNTS,BIIB,PRGO,JAZZ )
    Perrigo has purchased Fera's eye-care portfolio.
  2.

    Teva to Acquire MicroDose Therapeutx - Analyst Blog

    (AZN,TEVA,GSK,BIIB )
    This deal is in line with Teva's strategy of strengthening its position in the respiratory therapeutic area.
  3.

    Good News for Celgene's Pipeline - Analyst Blog

    (SNTS,CELG,BIIB,JAZZ )
    Celgene presented positive results on apremilast from a phase II study.
  4.

    Myriad: End to Legal Battle over Patents - Analyst Blog

    (ALXN,MYGN,BIIB,ANIK )
    Supreme Court reveals decision on Myriad's patent claims.
  5.

    Elan Shareholders Bring Management To Heel

    (ELN,THRX,BIIB )
    The rejection of Elan management's proposed transactions ought to accelerate the sale of the company.

  6. Good News for Celgene's Revlimid - Analyst Blog

    (CELG,BIIB,JAZZ,ANIK )
    The EC approved Revlimid for MDS.
Free Reports
  1.

    Get 10 Trading Lessons FREE

    Benefit from the knowledge of MarketClub co-founder Adam Hewison and our other trading experts, with this FREE series of educational emails and online content.
  2.

    Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
  3.

    Free Managed Futures Book

    Get the four benefits of managed futures as outlined in this booklet.
Marketplace
Trading Center